홈 › 비소세포폐암 › 캘리포니아 › Santa Rosa
CA Santa Rosa의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 17개가 Santa Rosa 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Kaiser Permanente-Santa Rosa, Santa Rosa
- Saint Helena Hospital, St. Helena · 14마일 거리
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중1/2상
- Research Site, Santa Rosa
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
피험자 모집 중3상
- Kaiser Permanente-Santa Rosa, Santa Rosa
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Providence Medical Foundation 1, Santa Rosa
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
피험자 모집 중2/3상
- Providence Medical Group - Santa Rosa, Santa Rosa
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
피험자 모집 중3상
- Providence Medical Foundation, Santa Rosa
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Providence Medical Group, Santa Rosa
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
피험자 모집 중2상
- Providence Medical Foundation (St. Joseph Heritage Healthcare), Santa Rosa
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
피험자 모집 중1/2상
- Providence Medical Foundation, Santa Rosa
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
피험자 모집 중1/2상
- Providence Medical Foundation, Santa Rosa
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Research Site, Santa Rosa
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Sutter Pacific Medical Foundation, Santa Rosa
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
피험자 모집 중1/2상
- St Joseph Heritage Healthcare, Santa Rosa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Sutter Pacific Medical Foundation, Santa Rosa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Sutter Pacific Medical Foundation, Santa Rosa
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
피험자 모집 중관찰 연구
- Kaiser Permanente-Santa Rosa, Santa Rosa
- Providence Medical Foundation - Santa Rosa, Santa Rosa
- Saint Helena Hospital, St. Helena · 14마일 거리
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
피험자 모집 중1/2상
- Providence Medical Foundation (site 209), Santa Rosa
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 121개
- Arlington, VA연구 104개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 57개
- Washington, DC연구 55개
Santa Rosa의 다른 연구
- 폐암연구 11개
- 암 (전체)연구 11개
- 유방암연구 11개
- 대장직장암연구 11개
- 전이성 암연구 9개
- 전립선암연구 9개
- 난소암연구 7개
- 췌장암연구 6개
- 자궁내막암연구 6개
- 결장암연구 5개
- 위암연구 5개
- 두경부암연구 4개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.